Stifel Financial’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,033
Closed -$113K 3378
2022
Q3
$113K Buy
+17,033
New +$113K ﹤0.01% 3091
2022
Q2
Sell
-56,679
Closed -$1.08M 3464
2022
Q1
$1.08M Buy
56,679
+18,120
+47% +$344K ﹤0.01% 2057
2021
Q4
$686K Sell
38,559
-7,285
-16% -$130K ﹤0.01% 2404
2021
Q3
$1.7M Sell
45,844
-1,188
-3% -$44K ﹤0.01% 1692
2021
Q2
$2.8M Buy
47,032
+3,517
+8% +$209K ﹤0.01% 1383
2021
Q1
$2.92M Buy
43,515
+2,257
+5% +$151K ﹤0.01% 1271
2020
Q4
$2.5M Sell
41,258
-10,776
-21% -$652K ﹤0.01% 1257
2020
Q3
$4.11M Sell
52,034
-3,986
-7% -$315K 0.01% 863
2020
Q2
$3.5M Sell
56,020
-7,161
-11% -$448K 0.01% 889
2020
Q1
$3.35M Buy
63,181
+2,853
+5% +$151K 0.01% 815
2019
Q4
$7.28M Buy
60,328
+6,279
+12% +$758K 0.02% 729
2019
Q3
$9.83M Buy
54,049
+97
+0.2% +$17.6K 0.03% 553
2019
Q2
$7.04M Buy
53,952
+8,194
+18% +$1.07M 0.02% 715
2019
Q1
$11.1M Sell
45,758
-2,996
-6% -$730K 0.03% 499
2018
Q4
$9.33M Buy
48,754
+7,284
+18% +$1.39M 0.03% 515
2018
Q3
$13.6M Buy
41,470
+2,734
+7% +$898K 0.04% 413
2018
Q2
$12M Buy
38,736
+1,483
+4% +$461K 0.04% 478
2018
Q1
$9.07M Buy
37,253
+463
+1% +$113K 0.03% 565
2017
Q4
$11.1M Sell
36,790
-4,008
-10% -$1.21M 0.04% 488
2017
Q3
$10.8M Sell
40,798
-243
-0.6% -$64.3K 0.04% 476
2017
Q2
$10.8M Buy
41,041
+32,454
+378% +$8.56M 0.04% 443
2017
Q1
$3.09M Buy
8,587
+4,777
+125% +$1.72M 0.01% 895
2016
Q4
$1.11M Buy
3,810
+3,218
+544% +$937K ﹤0.01% 1334
2016
Q3
$197K Sell
592
-4,641
-89% -$1.54M ﹤0.01% 2189
2016
Q2
$2.22M Sell
5,233
-312
-6% -$133K 0.01% 948
2016
Q1
$1.77M Sell
5,545
-78
-1% -$25K 0.01% 972
2015
Q4
$2.92M Sell
5,623
-451
-7% -$234K 0.02% 794
2015
Q3
$1.78M Sell
6,074
-28
-0.5% -$8.21K 0.01% 962
2015
Q2
$2.4M Buy
6,102
+1,460
+31% +$574K 0.01% 905
2015
Q1
$1.4M Buy
4,642
+3,400
+274% +$1.03M 0.01% 1117
2014
Q4
$276K Buy
1,242
+246
+25% +$54.7K ﹤0.01% 1914
2014
Q3
$231K Buy
996
+347
+53% +$80.5K ﹤0.01% 1936
2014
Q2
$143K Sell
649
-504
-44% -$111K ﹤0.01% 2050
2014
Q1
$364K Buy
+1,153
New +$364K ﹤0.01% 1608